Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
tRF16-mediated ALKBH5 Downregulation Drives Osteoarthritis P
2026-07-29
This study identifies tRF16 as a critical regulator in osteoarthritis, showing that it promotes disease progression by targeting the m6A demethylase ALKBH5 and destabilizing NFKBIA mRNA. These findings deepen our understanding of noncoding RNA involvement in OA and highlight potential biomarkers and therapeutic targets.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody in Advanced Immunoass
2026-07-29
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody elevates the sensitivity and reproducibility of immunofluorescence and flow cytometry, enabling precise mouse IgG detection even in complex signaling studies. Its robust signal amplification and low background streamline advanced workflows, making it a go-to tool for researchers tackling cellular signaling and biomarker quantification.
-
Brefeldin A: ATPase Inhibitor for ER Stress and Cancer Apopt
2026-07-28
Brefeldin A (BFA) is a potent ATPase inhibitor disrupting ER-to-Golgi trafficking and inducing apoptosis in cancer cells. It is widely used to model ER stress and vesicle transport inhibition. APExBIO’s BFA (SKU B1400) offers validated performance in diverse experimental systems.
-
Porcupine Inhibition for Sclerosteosis: LGK-974 in Bone Dise
2026-07-28
This study demonstrates that PORCN inhibition via LGK-974 can counteract pathological bone overgrowth in sclerosteosis, an ultra-rare high bone mass disorder. The findings highlight a new avenue for pharmacological intervention targeting Wnt/β-catenin signaling, with implications for rare bone diseases lacking effective non-surgical treatments.
-
Cisplatin (SKU A8321): Data-Driven Solutions for Cell Assays
2026-07-27
This article delivers scenario-driven, evidence-based guidance for maximizing reproducibility and sensitivity in cell viability and apoptosis assays using Cisplatin (SKU A8321). Drawing on recent literature and practical workflow insights, we address experimental design, protocol optimization, and product selection, helping researchers and technicians achieve robust, interpretable results in cancer research.
-
Pitavastatin (NK-104): Technical Guide for In Vitro Choleste
2026-07-27
Pitavastatin (NK-104) is a high-purity, potent HMG-CoA reductase inhibitor intended for precise in vitro inhibition of cholesterol biosynthesis. It is optimized for use in cellular and biochemical assays relevant to cardiovascular and atherosclerosis research, but is not validated for clinical or in vivo animal experiments.
-
TMRE and Mitochondrial Dysfunction: Strategic Advances for T
2026-07-26
This thought-leadership article explores how Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers translational researchers to dissect mitochondrial dysfunction and oxidative stress, particularly in the context of toxin-induced liver injury. Integrating mechanistic insights from recent studies on caspase-3-mediated mitochondrial impairment, it provides strategic guidance for leveraging TMRE in live-cell imaging, disease modeling, and therapeutic discovery. The article distinguishes itself by offering actionable protocols, evaluating the competitive landscape, and projecting future directions for mitochondrial research beyond standard product discussions.
-
Developmental SSRI Exposure Impairs Motivation via Opioid Ci
2026-07-25
This study reveals that developmental exposure to selective serotonin reuptake inhibitors (SSRIs) in mice leads to persistent motivational deficits extending into adolescence and adulthood. Notably, these deficits are resistant to further SSRI treatment but can be specifically reversed by pharmacological antagonism or viral knockdown of mu opioid receptors in the nucleus accumbens, highlighting a critical serotonergic-opioid circuit interaction relevant for depression research.
-
Cisplatin (CDDP): Systems-Level Insights for Tumor Modeling
2026-07-24
Discover how Cisplatin enables systems-level analysis of tumor growth inhibition and chemoresistance. This in-depth article explores advanced applications, experimental design, and translational implications for cancer research.
-
HRD1-SEL1L Ubiquitin Ligase Regulates Stress Granule Homeost
2026-07-24
Shi et al. (2024) demonstrate that the HRD1-SEL1L ubiquitin ligase complex, through the ubiquitin-proteasome system and ER stress signaling, specifically maintains heat shock-induced stress granule (SG) homeostasis. This mechanistic insight links proteostasis, selective ER stress pathways, and SG dynamics, informing future studies on neurodegeneration and proteinopathy.
-
Phosphatase Inhibitor Cocktail 3: Enhancing Phosphoprotein A
2026-07-23
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) empowers researchers to reliably preserve protein phosphorylation during extraction and analysis, enabling robust, reproducible phosphoproteomics. This APExBIO solution is tailored for workflows demanding precise serine/threonine phosphatase inhibition, especially in studies of dynamic cell signaling and bone biology.
-
Novel Allosteric PDK4 Inhibitors: Insights for Metabolic Dis
2026-07-23
This article examines the discovery and characterization of novel allosteric inhibitors targeting pyruvate dehydrogenase kinase 4 (PDK4), as reported in a recent medicinal chemistry study. The reference work identifies compounds with nanomolar potency, metabolic stability, and in vivo efficacy, providing a new scaffold for modulating mitochondrial energy metabolism in models of metabolic disease, allergy, and cancer.
-
EdU Imaging Kits (488): Decoding Proliferation in CRC and Be
2026-07-22
Explore the scientific depth of EdU Imaging Kits (488) for cell proliferation analysis, with a focus on S-phase DNA synthesis and advanced colorectal cancer research. This article reveals how mechanistic insights and innovative assay design empower next-generation cell cycle studies.
-
Applied Workflows with mCherry mRNA: Stability, Expression &
2026-07-22
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) from APExBIO enables robust, immune-evasive fluorescent protein expression for advanced cell and molecular workflows. Explore optimized protocols, innovative nanoparticle delivery, and practical troubleshooting strategies to maximize reporter gene mRNA performance.
-
Flexible 3D Nanocluster Arrays via Polymer Pen Lithography f
2026-07-21
The reference study demonstrates a scalable, programmable approach for fabricating highly ordered three-dimensional gold nanocluster arrays using polymer pen lithography. By tuning pattern parameters, the method delivers exceptional SERS sensitivity and reproducibility, advancing practical biosensing and analytical detection platforms.